Frequencies for first 10,000 rows of indi_pt variable in indi2017q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- 5q minus syndrome | 1 0.01 0.01 Abdominal discomfort | 10 0.10 0.11 Abdominal distension | 1 0.01 0.12 Abdominal pain | 6 0.06 0.18 Abdominal pain upper | 6 0.06 0.24 Abdominal symptom | 2 0.02 0.26 Abnormal behaviour | 1 0.01 0.27 Abortion | 1 0.01 0.28 Abortion induced | 7 0.07 0.35 Acarodermatitis | 1 0.01 0.36 Accidental exposure to product | 1 0.01 0.37 Acne | 2 0.02 0.39 Acquired haemophilia | 5 0.05 0.44 Acral overgrowth | 3 0.03 0.47 Acromegaly | 16 0.16 0.63 Acute coronary syndrome | 9 0.09 0.72 Acute graft versus host disease in in.. | 2 0.02 0.74 Acute lymphocytic leukaemia | 72 0.72 1.46 Acute lymphocytic leukaemia recurrent | 5 0.05 1.51 Acute monocytic leukaemia | 2 0.02 1.53 Acute myeloid leukaemia | 12 0.12 1.65 Acute myocardial infarction | 2 0.02 1.67 Acute respiratory failure | 2 0.02 1.69 Addison's disease | 1 0.01 1.70 Adenocarcinoma of appendix | 3 0.03 1.73 Adenomatous polyposis coli | 1 0.01 1.74 Adrenal insufficiency | 3 0.03 1.77 Adult T-cell lymphoma/leukaemia | 1 0.01 1.78 Affective disorder | 12 0.12 1.90 Age-related macular degeneration | 1 0.01 1.91 Aggression | 6 0.06 1.97 Agitation | 4 0.04 2.01 Allergy prophylaxis | 1 0.01 2.02 Allergy to chemicals | 6 0.06 2.08 Alopecia | 9 0.09 2.17 Alopecia areata | 1 0.01 2.18 Alveolar rhabdomyosarcoma | 1 0.01 2.19 Amyloidosis | 3 0.03 2.22 Anaemia | 10 0.10 2.32 Anaemia of malignant disease | 1 0.01 2.33 Anaemia prophylaxis | 1 0.01 2.34 Analgesic intervention supportive the.. | 1 0.01 2.35 Analgesic therapy | 20 0.20 2.55 Anaphylactic reaction | 1 0.01 2.56 Anaplastic astrocytoma | 1 0.01 2.57 Anaplastic large cell lymphoma T- and.. | 18 0.18 2.75 Androgen deficiency | 1 0.01 2.76 Androgen replacement therapy | 2 0.02 2.78 Androgenetic alopecia | 7 0.07 2.85 Anembryonic gestation | 1 0.01 2.86 Anger | 3 0.03 2.89 Angina pectoris | 23 0.23 3.12 Angiocentric lymphoma | 8 0.08 3.20 Angiogram | 1 0.01 3.21 Angiomyolipoma | 1 0.01 3.22 Angiosarcoma | 1 0.01 3.23 Angiotensin converting enzyme decreased | 2 0.02 3.25 Ankylosing spondylitis | 31 0.31 3.56 Anti-infective therapy | 4 0.04 3.60 Anti-neutrophil cytoplasmic antibody .. | 5 0.05 3.65 Antiallergic therapy | 2 0.02 3.67 Antibiotic prophylaxis | 6 0.06 3.73 Antibiotic therapy | 3 0.03 3.76 Anticoagulant therapy | 25 0.25 4.01 Antidepressant therapy | 2 0.02 4.03 Antiemetic supportive care | 4 0.04 4.07 Antifungal prophylaxis | 8 0.08 4.15 Antiinflammatory therapy | 4 0.04 4.19 Antioxidant therapy | 2 0.02 4.21 Antiphospholipid syndrome | 1 0.01 4.22 Antiplatelet therapy | 1 0.01 4.23 Antiviral prophylaxis | 7 0.07 4.30 Anxiety | 61 0.61 4.91 Anxiety disorder | 1 0.01 4.92 Anxiolytic therapy | 2 0.02 4.94 Application site erosion | 4 0.04 4.98 Arrhythmia | 10 0.10 5.08 Arrhythmia prophylaxis | 1 0.01 5.09 Arteriosclerosis | 2 0.02 5.11 Arteriosclerosis coronary artery | 2 0.02 5.13 Arthralgia | 20 0.20 5.33 Arthritis | 108 1.08 6.41 Arthritis infective | 1 0.01 6.42 Arthropod bite | 1 0.01 6.43 Asthenia | 3 0.03 6.46 Asthma | 145 1.45 7.91 Asthma late onset | 4 0.04 7.95 Asthma prophylaxis | 4 0.04 7.99 Astrocytoma, low grade | 1 0.01 8.00 Atrial fibrillation | 74 0.74 8.74 Atrophy | 1 0.01 8.75 Attention deficit/hyperactivity disor.. | 35 0.35 9.10 Autism spectrum disorder | 9 0.09 9.19 Autoimmune haemolytic anaemia | 1 0.01 9.20 Autoimmune thyroiditis | 4 0.04 9.24 Autonomic neuropathy | 2 0.02 9.26 B-cell lymphoma | 93 0.93 10.19 B-cell lymphoma recurrent | 1 0.01 10.20 Back disorder | 1 0.01 10.21 Back pain | 31 0.31 10.52 Bacteraemia | 3 0.03 10.55 Barrett's oesophagus | 2 0.02 10.57 Basedow's disease | 1 0.01 10.58 Behcet's syndrome | 2 0.02 10.60 Benign prostatic hyperplasia | 11 0.11 10.71 Bipolar I disorder | 6 0.06 10.77 Bipolar II disorder | 1 0.01 10.78 Bipolar disorder | 75 0.75 11.53 Bladder cancer | 3 0.03 11.56 Bladder catheterisation | 1 0.01 11.57 Bladder dilatation | 1 0.01 11.58 Bladder disorder | 2 0.02 11.60 Blood cholesterol | 9 0.09 11.69 Blood cholesterol abnormal | 18 0.18 11.87 Blood cholesterol increased | 31 0.31 12.18 Blood electrolytes | 6 0.06 12.24 Blood glucose abnormal | 3 0.03 12.27 Blood glucose increased | 1 0.01 12.28 Blood growth hormone decreased | 1 0.01 12.29 Blood immunoglobulin E increased | 1 0.01 12.30 Blood iron decreased | 1 0.01 12.31 Blood oestrogen | 1 0.01 12.32 Blood oestrogen decreased | 1 0.01 12.33 Blood pressure abnormal | 22 0.22 12.55 Blood pressure decreased | 1 0.01 12.56 Blood pressure increased | 5 0.05 12.61 Blood pressure measurement | 13 0.13 12.74 Blood prolactin increased | 1 0.01 12.75 Blood testosterone decreased | 1 0.01 12.76 Blood triglycerides abnormal | 2 0.02 12.78 Blood triglycerides increased | 1 0.01 12.79 Blood uric acid | 2 0.02 12.81 Blood uric acid decreased | 1 0.01 12.82 Body height below normal | 1 0.01 12.83 Bone density abnormal | 1 0.01 12.84 Bone density decreased | 2 0.02 12.86 Bone disorder | 16 0.16 13.02 Bone giant cell tumour | 2 0.02 13.04 Bone marrow conditioning regimen | 18 0.18 13.22 Bone pain | 7 0.07 13.29 Bone sarcoma | 11 0.11 13.40 Bradycardia | 1 0.01 13.41 Brain neoplasm benign | 1 0.01 13.42 Brain neoplasm malignant | 1 0.01 13.43 Brain oedema | 1 0.01 13.44 Brain stem glioma | 1 0.01 13.45 Breakthrough pain | 6 0.06 13.51 Breast cancer | 41 0.41 13.92 Breast cancer female | 7 0.07 13.99 Breast cancer metastatic | 30 0.30 14.29 Bronchitis | 24 0.24 14.53 Bronchitis chronic | 5 0.05 14.58 Bronchospasm | 1 0.01 14.59 Burkitt's lymphoma | 6 0.06 14.65 Burning sensation | 1 0.01 14.66 Cancer pain | 5 0.05 14.71 Capillaritis | 10 0.10 14.81 Carcinoid syndrome | 1 0.01 14.82 Carcinoid tumour | 5 0.05 14.87 Carcinoid tumour of the stomach | 1 0.01 14.88 Carcinoid tumour pulmonary | 1 0.01 14.89 Cardiac disorder | 23 0.23 15.12 Cardiac failure | 21 0.21 15.33 Cardiac failure chronic | 7 0.07 15.40 Cardiac failure congestive | 9 0.09 15.49 Cardioplegia | 1 0.01 15.50 Cardiovascular disorder | 2 0.02 15.52 Cardiovascular event prophylaxis | 17 0.17 15.69 Cataplexy | 1 0.01 15.70 Cataract | 1 0.01 15.71 Cellulitis | 7 0.07 15.78 Cerebellar infarction | 1 0.01 15.79 Cerebral artery embolism | 1 0.01 15.80 Cerebral disorder | 1 0.01 15.81 Cerebral infarction | 2 0.02 15.83 Cerebrovascular accident | 12 0.12 15.95 Cerebrovascular accident prophylaxis | 45 0.45 16.40 Cervix carcinoma | 2 0.02 16.42 Chalazion | 1 0.01 16.43 Chemotherapy | 14 0.14 16.57 Chest pain | 5 0.05 16.62 Chlamydial infection | 1 0.01 16.63 Cholangitis | 2 0.02 16.65 Cholangitis sclerosing | 1 0.01 16.66 Cholecystitis acute | 5 0.05 16.71 Choroidal neovascularisation | 1 0.01 16.72 Chronic gastritis | 5 0.05 16.77 Chronic hepatitis B | 1 0.01 16.78 Chronic hepatitis C | 25 0.25 17.03 Chronic infantile neurological cutane.. | 2 0.02 17.05 Chronic kidney disease | 2 0.02 17.07 Chronic lymphocytic leukaemia | 23 0.23 17.30 Chronic myeloid leukaemia | 51 0.51 17.81 Chronic obstructive pulmonary disease | 58 0.58 18.39 Chronic respiratory disease | 1 0.01 18.40 Chronic sinusitis | 1 0.01 18.41 Clear cell renal cell carcinoma | 7 0.07 18.48 Coagulation factor IX level | 1 0.01 18.49 Coagulation factor VIII level | 1 0.01 18.50 Coagulopathy | 7 0.07 18.57 Cognitive disorder | 1 0.01 18.58 Cold urticaria | 1 0.01 18.59 Colitis | 6 0.06 18.65 Colitis ulcerative | 18 0.18 18.83 Colon cancer | 19 0.19 19.02 Colon cancer metastatic | 1 0.01 19.03 Colon neoplasm | 2 0.02 19.05 Colorectal cancer | 10 0.10 19.15 Colorectal cancer metastatic | 33 0.33 19.48 Coma | 5 0.05 19.53 Complex regional pain syndrome | 5 0.05 19.58 Complications of transplanted heart | 2 0.02 19.60 Congenital cystic kidney disease | 1 0.01 19.61 Congenital neuropathy | 2 0.02 19.63 Conjunctivitis allergic | 1 0.01 19.64 Constipation | 43 0.43 20.07 Constipation prophylaxis | 4 0.04 20.11 Contraception | 22 0.22 20.33 Convulsion prophylaxis | 1 0.01 20.34 Coronary arterial stent insertion | 2 0.02 20.36 Coronary artery disease | 53 0.53 20.89 Coronary artery stenosis | 1 0.01 20.90 Cough | 6 0.06 20.96 Crohn's disease | 44 0.44 21.40 Cryoglobulinaemia | 3 0.03 21.43 Cryopyrin associated periodic syndrome | 3 0.03 21.46 Cystic fibrosis | 4 0.04 21.50 Cystitis | 2 0.02 21.52 Cytomegalovirus infection | 3 0.03 21.55 Cytomegalovirus viraemia | 1 0.01 21.56 Decreased appetite | 2 0.02 21.58 Deep vein thrombosis | 5 0.05 21.63 Dehydration | 1 0.01 21.64 Delirium | 2 0.02 21.66 Delivery | 2 0.02 21.68 Delusional disorder, unspecified type | 3 0.03 21.71 Dementia Alzheimer's type | 2 0.02 21.73 Dental care | 1 0.01 21.74 Depressed mood | 6 0.06 21.80 Depression | 100 1.00 22.80 Dermatomyositis | 1 0.01 22.81 Device related infection | 1 0.01 22.82 Diabetes mellitus | 84 0.84 23.66 Diabetic foot | 2 0.02 23.68 Diabetic nephropathy | 1 0.01 23.69 Diabetic neuropathy | 18 0.18 23.87 Diarrhoea | 6 0.06 23.93 Diffuse large B-cell lymphoma | 21 0.21 24.14 Disseminated tuberculosis | 1 0.01 24.15 Disturbance in social behaviour | 1 0.01 24.16 Diuretic therapy | 7 0.07 24.23 Dizziness | 4 0.04 24.27 Drug dependence | 1 0.01 24.28 Drug hypersensitivity | 1 0.01 24.29 Drug reaction with eosinophilia and s.. | 1 0.01 24.30 Drug toxicity prophylaxis | 4 0.04 24.34 Drug use disorder | 3 0.03 24.37 Dry eye | 7 0.07 24.44 Dry mouth | 1 0.01 24.45 Dry skin | 2 0.02 24.47 Dwarfism | 2 0.02 24.49 Dyslipidaemia | 12 0.12 24.61 Dysmenorrhoea | 2 0.02 24.63 Dyspepsia | 23 0.23 24.86 Dyspnoea | 22 0.22 25.08 Dysuria | 2 0.02 25.10 Ectopic pregnancy termination | 1 0.01 25.11 Eczema | 2 0.02 25.13 Electrolyte substitution therapy | 2 0.02 25.15 Embolism | 2 0.02 25.17 Emphysema | 6 0.06 25.23 Endometrial hyperplasia | 1 0.01 25.24 Endometriosis | 2 0.02 25.26 Enterocolitis | 3 0.03 25.29 Eosinophilic pustulosis | 1 0.01 25.30 Epigastric discomfort | 1 0.01 25.31 Epilepsy | 12 0.12 25.43 Erectile dysfunction | 10 0.10 25.53 Erythema | 3 0.03 25.56 Erythema nodosum | 5 0.05 25.61 Escherichia infection | 2 0.02 25.63 Essential hypertension | 2 0.02 25.65 Essential thrombocythaemia | 1 0.01 25.66 Euthanasia | 2 0.02 25.68 Ewing's sarcoma | 2 0.02 25.70 Exposure via body fluid | 1 0.01 25.71 Extrapulmonary tuberculosis | 1 0.01 25.72 Extrapyramidal disorder | 3 0.03 25.75 Eye infection staphylococcal | 1 0.01 25.76 Eye inflammation | 1 0.01 25.77 Fabry's disease | 13 0.13 25.90 Factor IX deficiency | 2 0.02 25.92 Factor V Leiden mutation | 5 0.05 25.97 Faeces hard | 1 0.01 25.98 Fallopian tube cancer | 5 0.05 26.03 Fatigue | 5 0.05 26.08 Febrile neutropenia | 16 0.16 26.24 Feeding disorder | 2 0.02 26.26 Femur fracture | 2 0.02 26.28 Fibromyalgia | 30 0.30 26.58 Fluid imbalance | 2 0.02 26.60 Fluid retention | 4 0.04 26.64 Focal dyscognitive seizures | 1 0.01 26.65 Focal segmental glomerulosclerosis | 4 0.04 26.69 Folate deficiency | 1 0.01 26.70 Full blood count abnormal | 1 0.01 26.71 Functional gastrointestinal disorder | 2 0.02 26.73 Fungal infection | 4 0.04 26.77 Gait disturbance | 4 0.04 26.81 Gastric bypass | 1 0.01 26.82 Gastric cancer | 3 0.03 26.85 Gastric disorder | 15 0.15 27.00 Gastric infection | 1 0.01 27.01 Gastric ulcer | 1 0.01 27.02 Gastritis | 8 0.08 27.10 Gastritis prophylaxis | 7 0.07 27.17 Gastroenteritis | 4 0.04 27.21 Gastroenteritis bacterial | 3 0.03 27.24 Gastrointestinal disorder | 3 0.03 27.27 Gastrointestinal inflammation | 5 0.05 27.32 Gastrointestinal motility disorder | 1 0.01 27.33 Gastrointestinal pain | 5 0.05 27.38 Gastrointestinal stromal tumour | 4 0.04 27.42 Gastrooesophageal cancer | 5 0.05 27.47 Gastrooesophageal reflux disease | 69 0.69 28.16 Gastrooesophageal reflux prophylaxis | 2 0.02 28.18 Generalised tonic-clonic seizure | 4 0.04 28.22 Genital herpes | 1 0.01 28.23 Genitourinary symptom | 1 0.01 28.24 Germ cell cancer | 4 0.04 28.28 Gingival pain | 1 0.01 28.29 Glaucoma | 5 0.05 28.34 Glioblastoma multiforme | 4 0.04 28.38 Glucose tolerance impaired | 1 0.01 28.39 Glycogen storage disease type II | 1 0.01 28.40 Gout | 6 0.06 28.46 Graft versus host disease | 2 0.02 28.48 Granulomatosis with polyangiitis | 1 0.01 28.49 Growth hormone deficiency | 8 0.08 28.57 Growth retardation | 3 0.03 28.60 HER-2 positive breast cancer | 59 0.59 29.19 HER-2 positive gastric cancer | 8 0.08 29.27 HIV infection | 72 0.72 29.99 Haemarthrosis | 1 0.01 30.00 Haemoglobin abnormal | 1 0.01 30.01 Haemoglobin decreased | 1 0.01 30.02 Haemolytic uraemic syndrome | 11 0.11 30.13 Haemoptysis | 2 0.02 30.15 Haemorrhage | 4 0.04 30.19 Hair disorder | 1 0.01 30.20 Hallucination, auditory | 2 0.02 30.22 Hallucination, visual | 1 0.01 30.23 Headache | 15 0.15 30.38 Heart rate abnormal | 3 0.03 30.41 Heart rate decreased | 2 0.02 30.43 Heart rate increased | 2 0.02 30.45 Heart transplant | 15 0.15 30.60 Hepatic cancer | 1 0.01 30.61 Hepatic candidiasis | 2 0.02 30.63 Hepatic cirrhosis | 1 0.01 30.64 Hepatic failure | 2 0.02 30.66 Hepatitis B | 2 0.02 30.68 Hepatitis C | 16 0.16 30.84 Hepatoblastoma | 1 0.01 30.85 Hepatocellular carcinoma | 6 0.06 30.91 Hernia | 1 0.01 30.92 Herpes simplex | 9 0.09 31.01 Herpes zoster | 4 0.04 31.05 Hiatus hernia | 6 0.06 31.11 Hodgkin's disease | 19 0.19 31.30 Hormone replacement therapy | 11 0.11 31.41 Hormone therapy | 2 0.02 31.43 Hormone-refractory prostate cancer | 11 0.11 31.54 Hot flush | 1 0.01 31.55 Humerus fracture | 2 0.02 31.57 Huntington's disease | 1 0.01 31.58 Hydromyelia | 1 0.01 31.59 Hyper IgD syndrome | 3 0.03 31.62 Hypercalcaemia | 1 0.01 31.63 Hypercholesterolaemia | 14 0.14 31.77 Hypercoagulation | 5 0.05 31.82 Hyperglycaemia | 1 0.01 31.83 Hyperhidrosis | 1 0.01 31.84 Hyperlipidaemia | 25 0.25 32.09 Hyperprolactinaemia | 1 0.01 32.10 Hypersensitivity | 18 0.18 32.28 Hypersensitivity vasculitis | 10 0.10 32.38 Hypertension | 237 2.37 34.75 Hypertonic bladder | 6 0.06 34.81 Hypertriglyceridaemia | 2 0.02 34.83 Hypertrophic cardiomyopathy | 3 0.03 34.86 Hyperuricaemia | 20 0.20 35.06 Hypoacusis | 1 0.01 35.07 Hypoaesthesia | 2 0.02 35.09 Hypoalbuminaemia | 1 0.01 35.10 Hypocalcaemia | 2 0.02 35.12 Hypogonadism | 1 0.01 35.13 Hypokalaemia | 6 0.06 35.19 Hyponatraemia | 13 0.13 35.32 Hypopharyngeal cancer | 2 0.02 35.34 Hypophosphataemia | 1 0.01 35.35 Hypopituitarism | 7 0.07 35.42 Hypotension | 2 0.02 35.44 Hypothyroidism | 23 0.23 35.67 Hypovitaminosis | 4 0.04 35.71 Hysterectomy | 3 0.03 35.74 Ileus | 1 0.01 35.75 Ill-defined disorder | 2 0.02 35.77 Imaging procedure | 4 0.04 35.81 Immune system disorder | 2 0.02 35.83 Immune thrombocytopenic purpura | 19 0.19 36.02 Immune-mediated necrotising myopathy | 3 0.03 36.05 Immunisation | 1 0.01 36.06 Immunosuppressant drug therapy | 17 0.17 36.23 Immunosuppression | 6 0.06 36.29 Impulse-control disorder | 1 0.01 36.30 Impulsive behaviour | 3 0.03 36.33 Incontinence | 3 0.03 36.36 Induction of anaesthesia | 7 0.07 36.43 Infarction | 1 0.01 36.44 Infected skin ulcer | 1 0.01 36.45 Infection | 20 0.20 36.65 Infection prophylaxis | 27 0.27 36.92 Inflammation | 6 0.06 36.98 Influenza | 1 0.01 36.99 Infusion related reaction | 5 0.05 37.04 Insomnia | 41 0.41 37.45 Intellectual disability | 3 0.03 37.48 Interstitial lung disease | 1 0.01 37.49 Intervertebral disc protrusion | 2 0.02 37.51 Intestinal obstruction | 2 0.02 37.53 Intracardiac thrombus | 2 0.02 37.55 Invasive ductal breast carcinoma | 2 0.02 37.57 Invasive lobular breast carcinoma | 3 0.03 37.60 Iodine deficiency | 1 0.01 37.61 Iritis | 2 0.02 37.63 Iron deficiency anaemia | 2 0.02 37.65 Iron overload | 1 0.01 37.66 Irritable bowel syndrome | 4 0.04 37.70 Ischaemic cardiomyopathy | 1 0.01 37.71 Ischaemic stroke | 4 0.04 37.75 Jaundice | 1 0.01 37.76 Joint arthroplasty | 1 0.01 37.77 Joint swelling | 2 0.02 37.79 Juvenile idiopathic arthritis | 3 0.03 37.82 Knee arthroplasty | 1 0.01 37.83 Labyrinthitis | 1 0.01 37.84 Laceration | 1 0.01 37.85 Laxative supportive care | 2 0.02 37.87 Left ventricular dysfunction | 7 0.07 37.94 Leishmaniasis | 1 0.01 37.95 Lesion excision | 1 0.01 37.96 Leukaemia | 1 0.01 37.97 Libido disorder | 1 0.01 37.98 Ligament rupture | 2 0.02 38.00 Limb discomfort | 2 0.02 38.02 Lipids | 1 0.01 38.03 Lipids increased | 1 0.01 38.04 Liver disorder | 2 0.02 38.06 Liver transplant | 4 0.04 38.10 Local anaesthesia | 1 0.01 38.11 Low density lipoprotein increased | 2 0.02 38.13 Lower gastrointestinal haemorrhage | 2 0.02 38.15 Lumbar spinal stenosis | 1 0.01 38.16 Lung adenocarcinoma | 4 0.04 38.20 Lung carcinoma cell type unspecified .. | 1 0.01 38.21 Lung disorder | 1 0.01 38.22 Lung neoplasm malignant | 3 0.03 38.25 Lupus nephritis | 17 0.17 38.42 Lymphadenitis bacterial | 1 0.01 38.43 Lymphangiectasia intestinal | 1 0.01 38.44 Lymphocytic leukaemia | 12 0.12 38.56 Lymphoedema | 2 0.02 38.58 Lymphoma | 7 0.07 38.65 Macular oedema | 1 0.01 38.66 Magnesium deficiency | 1 0.01 38.67 Major depression | 26 0.26 38.93 Malabsorption | 1 0.01 38.94 Malaise | 1 0.01 38.95 Malignant hypertension | 3 0.03 38.98 Malignant melanoma | 15 0.15 39.13 Malignant peritoneal neoplasm | 3 0.03 39.16 Malnutrition | 2 0.02 39.18 Mania | 4 0.04 39.22 Mantle cell lymphoma | 9 0.09 39.31 Maternal exposure timing unspecified | 5 0.05 39.36 Meniere's disease | 1 0.01 39.37 Meningitis bacterial | 3 0.03 39.40 Menopausal symptoms | 2 0.02 39.42 Menopause | 1 0.01 39.43 Menorrhagia | 3 0.03 39.46 Menstrual cycle management | 1 0.01 39.47 Menstrual disorder | 1 0.01 39.48 Mental disorder | 17 0.17 39.65 Mental impairment | 3 0.03 39.68 Meralgia paraesthetica | 1 0.01 39.69 Mesothelioma | 3 0.03 39.72 Metastases to bone | 20 0.20 39.92 Metastases to bone marrow | 1 0.01 39.93 Metastases to liver | 6 0.06 39.99 Metastases to lung | 8 0.08 40.07 Metastases to peritoneum | 7 0.07 40.14 Metastases to skin | 1 0.01 40.15 Metastases to thorax | 8 0.08 40.23 Metastatic carcinoid tumour | 1 0.01 40.24 Metastatic carcinoma of the bladder | 2 0.02 40.26 Metastatic malignant melanoma | 6 0.06 40.32 Metastatic renal cell carcinoma | 173 1.73 42.05 Migraine | 19 0.19 42.24 Mineral supplementation | 9 0.09 42.33 Mixed incontinence | 2 0.02 42.35 Monoclonal gammopathy | 3 0.03 42.38 Mood altered | 1 0.01 42.39 Muckle-Wells syndrome | 2 0.02 42.41 Mucopolysaccharidosis I | 2 0.02 42.43 Mucosal inflammation | 4 0.04 42.47 Multiple allergies | 6 0.06 42.53 Multiple sclerosis | 158 1.58 44.11 Multiple sclerosis relapse | 2 0.02 44.13 Muscle relaxant therapy | 5 0.05 44.18 Muscle spasms | 23 0.23 44.41 Muscle spasticity | 1 0.01 44.42 Muscular weakness | 1 0.01 44.43 Musculoskeletal discomfort | 2 0.02 44.45 Musculoskeletal disorder | 1 0.01 44.46 Musculoskeletal pain | 1 0.01 44.47 Myalgia | 5 0.05 44.52 Mycobacterium avium complex infection | 2 0.02 44.54 Mycosis fungoides | 15 0.15 44.69 Myelodysplastic syndrome | 10 0.10 44.79 Myelofibrosis | 17 0.17 44.96 Myocardial infarction | 14 0.14 45.10 Myocardial ischaemia | 8 0.08 45.18 Myopathy | 5 0.05 45.23 Narcolepsy | 11 0.11 45.34 Nasal congestion | 3 0.03 45.37 Nasal dryness | 1 0.01 45.38 Nasal polyps | 1 0.01 45.39 Nasal sinus cancer | 2 0.02 45.41 Nasopharyngitis | 7 0.07 45.48 Nausea | 32 0.32 45.80 Neck pain | 3 0.03 45.83 Negativism | 3 0.03 45.86 Neoplasm | 3 0.03 45.89 Neoplasm malignant | 22 0.22 46.11 Nephroblastoma | 1 0.01 46.12 Nephrogenic anaemia | 1 0.01 46.13 Nephrolithiasis | 3 0.03 46.16 Nephroprotective therapy | 1 0.01 46.17 Nephrotic syndrome | 12 0.12 46.29 Nerve injury | 4 0.04 46.33 Nervous system disorder | 2 0.02 46.35 Nervousness | 1 0.01 46.36 Neuralgia | 20 0.20 46.56 Neuroblastoma | 1 0.01 46.57 Neuroblastoma recurrent | 3 0.03 46.60 Neuroendocrine carcinoma | 2 0.02 46.62 Neuroendocrine carcinoma metastatic | 12 0.12 46.74 Neuroendocrine tumour | 19 0.19 46.93 Neuromuscular blockade reversal | 1 0.01 46.94 Neuromuscular blocking therapy | 1 0.01 46.95 Neuropathy peripheral | 32 0.32 47.27 Neutropenia | 1 0.01 47.28 Neutrophil count decreased | 1 0.01 47.29 Night sweats | 1 0.01 47.30 Nocturia | 2 0.02 47.32 Non-Hodgkin's lymphoma | 26 0.26 47.58 Non-Hodgkin's lymphoma unspecified hi.. | 5 0.05 47.63 Non-small cell lung cancer | 35 0.35 47.98 Normal tension glaucoma | 2 0.02 48.00 Nuclear magnetic resonance imaging | 8 0.08 48.08 Nuclear magnetic resonance imaging ab.. | 1 0.01 48.09 Nutritional supplementation | 13 0.13 48.22 Obsessive-compulsive disorder | 4 0.04 48.26 Oedema | 5 0.05 48.31 Oedema peripheral | 5 0.05 48.36 Oesophageal achalasia | 1 0.01 48.37 Oesophageal carcinoma | 5 0.05 48.42 Oesophageal disorder | 5 0.05 48.47 Off label use | 10 0.10 48.57 Onychomycosis | 1 0.01 48.58 Opportunistic infection prophylaxis | 2 0.02 48.60 Oppositional defiant disorder | 1 0.01 48.61 Oral contraception | 1 0.01 48.62 Oral fungal infection | 6 0.06 48.68 Oral herpes | 1 0.01 48.69 Oropharyngeal pain | 3 0.03 48.72 Osteitis deformans | 13 0.13 48.85 Osteoarthritis | 40 0.40 49.25 Osteomyelitis | 2 0.02 49.27 Osteonecrosis | 1 0.01 49.28 Osteopenia | 64 0.64 49.92 Osteoporosis | 242 2.42 52.34 Osteoporosis postmenopausal | 4 0.04 52.38 Osteoporosis prophylaxis | 12 0.12 52.50 Osteosarcoma | 14 0.14 52.64 Osteosarcoma metastatic | 5 0.05 52.69 Ovarian cancer | 14 0.14 52.83 Ovarian epithelial cancer | 2 0.02 52.85 Pain | 185 1.85 54.70 Pain in extremity | 7 0.07 54.77 Pain management | 45 0.45 55.22 Palpitations | 1 0.01 55.23 Pancreas islet cell transplant | 5 0.05 55.28 Pancreatic carcinoma | 2 0.02 55.30 Pancreatic carcinoma metastatic | 6 0.06 55.36 Pancreatic failure | 2 0.02 55.38 Pancreatic neuroendocrine tumour | 5 0.05 55.43 Pancreatic neuroendocrine tumour meta.. | 3 0.03 55.46 Panic attack | 2 0.02 55.48 Panic disorder | 4 0.04 55.52 Paraesthesia | 1 0.01 55.53 Paranoia | 20 0.20 55.73 Paraspinal abscess | 3 0.03 55.76 Parkinson's disease | 7 0.07 55.83 Parkinsonism | 1 0.01 55.84 Parotitis | 1 0.01 55.85 Paroxysmal nocturnal haemoglobinuria | 15 0.15 56.00 Partial seizures | 1 0.01 56.01 Pelvic pain | 1 0.01 56.02 Pelvic venous thrombosis | 1 0.01 56.03 Peptic ulcer | 1 0.01 56.04 Pericardial effusion | 1 0.01 56.05 Perinatal depression | 2 0.02 56.07 Periorbital cellulitis | 1 0.01 56.08 Peripheral T-cell lymphoma unspecifie.. | 6 0.06 56.14 Peripheral arterial occlusive disease | 8 0.08 56.22 Peripheral circulatory failure | 1 0.01 56.23 Peripheral swelling | 2 0.02 56.25 Peripheral venous disease | 1 0.01 56.26 Peritoneal dialysis | 3 0.03 56.29 Persistent depressive disorder | 1 0.01 56.30 Personality disorder | 2 0.02 56.32 Petit mal epilepsy | 1 0.01 56.33 Phantom pain | 1 0.01 56.34 Pharyngitis | 1 0.01 56.35 Plantar fasciitis | 1 0.01 56.36 Plasma cell leukaemia | 2 0.02 56.38 Plasma cell myeloma | 156 1.56 57.94 Plasma cell myeloma recurrent | 2 0.02 57.96 Platelet disorder | 1 0.01 57.97 Pleural effusion | 1 0.01 57.98 Pleurisy | 2 0.02 58.00 Pneumocystis jirovecii pneumonia | 3 0.03 58.03 Pneumonia | 21 0.21 58.24 Pneumonia bacterial | 1 0.01 58.25 Pneumonia mycoplasmal | 5 0.05 58.30 Pneumonitis | 1 0.01 58.31 Pollakiuria | 1 0.01 58.32 Polycystic ovaries | 1 0.01 58.33 Polycythaemia vera | 1 0.01 58.34 Polymyalgia rheumatica | 3 0.03 58.37 Polyneuropathy | 4 0.04 58.41 Polyuria | 1 0.01 58.42 Poor peripheral circulation | 3 0.03 58.45 Portopulmonary hypertension | 1 0.01 58.46 Post herpetic neuralgia | 2 0.02 58.48 Post laminectomy syndrome | 1 0.01 58.49 Postoperative wound infection | 2 0.02 58.51 Postpartum haemorrhage | 1 0.01 58.52 Prader-Willi syndrome | 1 0.01 58.53 Premedication | 79 0.79 59.32 Primary amyloidosis | 3 0.03 59.35 Primary insulin like growth factor-1 .. | 1 0.01 59.36 Primary myelofibrosis | 2 0.02 59.38 Proctalgia | 2 0.02 59.40 Proctitis | 1 0.01 59.41 Product use in unapproved indication | 1 0.01 59.42 Product used for unknown indication | 2,309 23.09 82.51 Productive cough | 1 0.01 82.52 Prolactin-producing pituitary tumour | 1 0.01 82.53 Prolapse | 1 0.01 82.54 Prophylaxis | 243 2.43 84.97 Prophylaxis against diarrhoea | 1 0.01 84.98 Prophylaxis against gastrointestinal .. | 8 0.08 85.06 Prophylaxis against graft versus host.. | 8 0.08 85.14 Prophylaxis against transplant reject.. | 24 0.24 85.38 Prophylaxis of nausea and vomiting | 12 0.12 85.50 Prostate cancer | 52 0.52 86.02 Prostate cancer metastatic | 4 0.04 86.06 Prostate cancer stage II | 1 0.01 86.07 Prostate cancer stage IV | 1 0.01 86.08 Prostatic disorder | 4 0.04 86.12 Prostatic obstruction | 1 0.01 86.13 Prostatic specific antigen increased | 2 0.02 86.15 Prostatomegaly | 1 0.01 86.16 Pruritus | 6 0.06 86.22 Pseudomonas infection | 3 0.03 86.25 Psoriasis | 78 0.78 87.03 Psoriatic arthropathy | 36 0.36 87.39 Psychomotor hyperactivity | 1 0.01 87.40 Psychotic disorder | 44 0.44 87.84 Psychotic symptom | 1 0.01 87.85 Pulmonary arterial hypertension | 31 0.31 88.16 Pulmonary embolism | 5 0.05 88.21 Pulmonary hypertension | 14 0.14 88.35 Pulmonary tuberculosis | 1 0.01 88.36 Pyrexia | 19 0.19 88.55 Q fever | 4 0.04 88.59 Radioembolisation | 1 0.01 88.60 Radius fracture | 2 0.02 88.62 Rash | 2 0.02 88.64 Raynaud's phenomenon | 7 0.07 88.71 Rectal cancer | 17 0.17 88.88 Relapsing-remitting multiple sclerosis | 21 0.21 89.09 Relaxation therapy | 2 0.02 89.11 Renal cancer recurrent | 1 0.01 89.12 Renal cell carcinoma | 33 0.33 89.45 Renal failure | 2 0.02 89.47 Renal transplant | 26 0.26 89.73 Respiratory disorder | 3 0.03 89.76 Respiratory distress | 1 0.01 89.77 Respiratory moniliasis | 1 0.01 89.78 Restless legs syndrome | 13 0.13 89.91 Retinal vein occlusion | 5 0.05 89.96 Retroperitoneal cancer | 5 0.05 90.01 Rhabdomyosarcoma | 6 0.06 90.07 Rheumatic disorder | 12 0.12 90.19 Rheumatoid arthritis | 326 3.26 93.45 Rhinitis allergic | 4 0.04 93.49 Rib fracture | 3 0.03 93.52 Rosacea | 2 0.02 93.54 Routine health maintenance | 14 0.14 93.68 Salivary hypersecretion | 5 0.05 93.73 Sarcoidosis | 4 0.04 93.77 Scan with contrast | 2 0.02 93.79 Schizoaffective disorder | 5 0.05 93.84 Schizoaffective disorder depressive t.. | 2 0.02 93.86 Schizophrenia | 103 1.03 94.89 Sciatic nerve injury | 1 0.01 94.90 Sciatica | 2 0.02 94.92 Scleroderma | 3 0.03 94.95 Scleroderma associated digital ulcer | 1 0.01 94.96 Seasonal allergy | 4 0.04 95.00 Seborrhoeic dermatitis | 1 0.01 95.01 Secondary hypertension | 1 0.01 95.02 Secondary progressive multiple sclero.. | 2 0.02 95.04 Sedation | 3 0.03 95.07 Sedative therapy | 3 0.03 95.10 Seizure | 26 0.26 95.36 Seminoma | 9 0.09 95.45 Senile osteoporosis | 1 0.01 95.46 Sensory neuropathy hereditary | 1 0.01 95.47 Sepsis | 8 0.08 95.55 Seronegative arthritis | 1 0.01 95.56 Sinusitis | 5 0.05 95.61 Sjogren's syndrome | 1 0.01 95.62 Skin ulcer | 5 0.05 95.67 Skin wrinkling | 1 0.01 95.68 Sleep disorder | 26 0.26 95.94 Sleep disorder therapy | 2 0.02 95.96 Small cell lung cancer limited stage | 2 0.02 95.98 Small for dates baby | 1 0.01 95.99 Smear cervix | 1 0.01 96.00 Smoking cessation therapy | 7 0.07 96.07 Social fear | 3 0.03 96.10 Soft tissue disorder | 2 0.02 96.12 Somatic symptom disorder | 1 0.01 96.13 Spinal anaesthesia | 3 0.03 96.16 Spinal cord injury | 1 0.01 96.17 Spinal disorder | 1 0.01 96.18 Spinal osteoarthritis | 2 0.02 96.20 Spinal pain | 4 0.04 96.24 Splenectomy | 1 0.01 96.25 Splenic abscess | 1 0.01 96.26 Splenic lesion | 1 0.01 96.27 Sputum retention | 1 0.01 96.28 Squamous cell carcinoma of head and n.. | 12 0.12 96.40 Staphylococcal infection | 1 0.01 96.41 Staphylococcal mediastinitis | 2 0.02 96.43 Status epilepticus | 6 0.06 96.49 Stem cell transplant | 5 0.05 96.54 Stent placement | 23 0.23 96.77 Still's disease | 1 0.01 96.78 Stomatitis | 5 0.05 96.83 Stress | 3 0.03 96.86 Strongyloidiasis | 2 0.02 96.88 Suicidal ideation | 2 0.02 96.90 Supplementation therapy | 27 0.27 97.17 Supraventricular tachycardia | 5 0.05 97.22 Surgery | 1 0.01 97.23 Surgical preconditioning | 1 0.01 97.24 Swelling | 3 0.03 97.27 Synovial sarcoma | 5 0.05 97.32 Syphilis | 1 0.01 97.33 Systemic lupus erythematosus | 8 0.08 97.41 Systemic sclerosis pulmonary | 1 0.01 97.42 Tachycardia | 1 0.01 97.43 Tendonitis | 1 0.01 97.44 Thalassaemia | 1 0.01 97.45 Thermal burn | 1 0.01 97.46 Thinking abnormal | 1 0.01 97.47 Thrombocytopenia | 2 0.02 97.49 Thrombosis | 2 0.02 97.51 Thrombosis prophylaxis | 38 0.38 97.89 Thymoma malignant | 2 0.02 97.91 Thyroid cancer | 8 0.08 97.99 Thyroid cancer metastatic | 2 0.02 98.01 Thyroid disorder | 15 0.15 98.16 Thyroid therapy | 1 0.01 98.17 Thyroidectomy | 2 0.02 98.19 Tonsillitis | 3 0.03 98.22 Tooth disorder | 1 0.01 98.23 Tooth infection | 2 0.02 98.25 Toothache | 1 0.01 98.26 Tourette's disorder | 2 0.02 98.28 Transient ischaemic attack | 9 0.09 98.37 Trigeminal neuralgia | 1 0.01 98.38 Tuberculosis | 1 0.01 98.39 Tumour lysis syndrome | 2 0.02 98.41 Turner's syndrome | 2 0.02 98.43 Type 1 diabetes mellitus | 19 0.19 98.62 Type 2 diabetes mellitus | 53 0.53 99.15 Ulcer | 1 0.01 99.16 Upper respiratory tract infection | 3 0.03 99.19 Ureterolithiasis | 3 0.03 99.22 Urinary incontinence | 2 0.02 99.24 Urinary tract disorder | 2 0.02 99.26 Urinary tract infection | 7 0.07 99.33 Uterine cancer | 3 0.03 99.36 Uterine cervix dilation procedure | 1 0.01 99.37 Uterine operation | 1 0.01 99.38 Uveitis | 4 0.04 99.42 Vaginal infection | 1 0.01 99.43 Vascular malformation | 1 0.01 99.44 Vascular occlusion | 1 0.01 99.45 Vasculitis | 1 0.01 99.46 Venoocclusive liver disease | 2 0.02 99.48 Ventricular tachycardia | 4 0.04 99.52 Viral upper respiratory tract infection | 4 0.04 99.56 Visual impairment | 2 0.02 99.58 Vitamin B12 decreased | 1 0.01 99.59 Vitamin B2 deficiency | 1 0.01 99.60 Vitamin D decreased | 1 0.01 99.61 Vitamin D deficiency | 3 0.03 99.64 Vitamin supplementation | 10 0.10 99.74 Vitreous floaters | 1 0.01 99.75 Vomiting | 13 0.13 99.88 Von Hippel-Lindau disease | 1 0.01 99.89 Vulvitis | 1 0.01 99.90 Weight control | 1 0.01 99.91 Wheezing | 7 0.07 99.98 White blood cell count decreased | 1 0.01 99.99 pH body fluid abnormal | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 8 Feb 2018